Table 1.
Summary of studies on the role of antibiotics in colon and rectal cancers.
Type of Antibiotics | Study Type | Major Finding | Reference |
---|---|---|---|
Penicillin | Human, retrospective | Exposure to multiple courses of penicillin increases colon cancer risk | [34] |
Overall antibiotics | Human, retrospective | Exposure to antibiotics increases the relative risk for primary colon cancer | [47] |
Oral use of ampicillin/amoxicillin | Human, retrospective | Oral use of ampicillin/amoxicillin increased the risk of colon cancer | [35] |
Oral use of tetracyclines | Human, retrospective | Oral use of tetracyclines reduced the risk of rectal cancer | [35] |
Oral administration of the mix of antibiotics: ampicillin/neomycin/ metronidazole/ vancomycin |
Animal study, azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced model of colitis-associated cancer (CAC) |
Pretreatment of animals with the mix of antibiotics 3 weeks prior, but not during AOM/DSS treatment, did not decrease tumorigenesis | [48] |
Oral or intravenous medication of one of the seven antibiotic classes, including penicillins, cephalosporins, macrolides, tetracyclines, sulfonamides, quinolones, and nitroimidazoles | Human, retrospective | Antibiotic exposure could be during therapy with bevacizumab inversely associated with the mortality in metastatic colorectal cancer | [49] |